相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients
Angelo Silverio et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
The Norwegian Patient Registry and the Norwegian Registry for Primary Health Care: Research potential of two nationwide health-care registries
Inger Johanne Bakken et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2020)
Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation A Nationwide Cohort Study
Tze-Fan Chao et al.
CHEST (2020)
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation The NAXOS Study
Eric Van Ganse et al.
STROKE (2020)
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants
Alan John Camm et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation
Giuseppe Patti et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study
Tomas Forslund et al.
EUROPACE (2018)
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study
Tze-Fan Chao et al.
CIRCULATION (2018)
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study
Gregory Y. H. Lip et al.
STROKE (2018)
Bias Due to Confounders for the Exposure-Competing Risk Relationship
Catherine R. Lesko et al.
EPIDEMIOLOGY (2017)
Effects of dabigatran according to age in atrial fibrillation
Mandy N. Lauw et al.
HEART (2017)
Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation)
Giuseppe Patti et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
Sigrun Halvorsen et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2017)
Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial
Kuan H. Ng et al.
AGE AND AGEING (2016)
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
Eri Toda Kato et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Active-comparator design and new-user design in observational studies
Kazuki Yoshida et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
Jonathan L. Halperin et al.
CIRCULATION (2014)
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
Sigrun Halvorsen et al.
EUROPEAN HEART JOURNAL (2014)
Competing risks analyses: objectives and approaches
Marcel Wolbers et al.
EUROPEAN HEART JOURNAL (2014)
The Nordic prescription databases as a resource for pharmacoepidemiological researcha literature review
B. Wettermark et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Estimating the Power of Indirect Comparisons: A Simulation Study
Edward J. Mills et al.
PLOS ONE (2011)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
分享论文
